<DOC>
	<DOCNO>NCT00871611</DOCNO>
	<brief_summary>The prevalence Anderson - Fabry disease patient leave ventricular hypertrophy unclear . The investigator examine urine - α - Galactosidase activity globotriaosylceramide isoforms patient .</brief_summary>
	<brief_title>Viennese Prevalence Study Anderson-Fabry Disease</brief_title>
	<detailed_description>Anderson - Fabry disease ( AFD ) rare , X - link hereditary systemic lysosomal storage disorder usually affect heart . The reported incidence AFD 1 117000 1 240000 live birth . Due deficiency enzyme α - galactosidase , glycosphingo-lipids , primarily globotriaosylceramide , store also endothelial myocardial cell , lead morphologic functional change . AFD-cardiomyopathy progress age course disease , lead reduced life expectancy . The investigator hypothesize , AFD could underdiagnosed patient mild moderate leave ventricular myocardial hypertrophy . Early diagnosis AFD may relevant since affected patient might benefit enzyme replacement therapy early stage disease . The investigator examine 4000 consecutive patient echocardiographically measure interventricular septum thickness ≥ 12mm . Urine sample collect Gb3-isoforms , creatinine α - Galactosidase activity measure .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Fabry Disease</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<criteria>Patients myocardial septum wall thickness ≥ 12mm Patients &lt; 18 year Patients unable provide urine sample</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Hereditary</keyword>
	<keyword>Anderson-Fabry</keyword>
	<keyword>prevalence</keyword>
	<keyword>heart</keyword>
	<keyword>hypertrophy</keyword>
	<keyword>urine</keyword>
	<keyword>globotriaosylceramide</keyword>
	<keyword>isoforms</keyword>
	<keyword>α - Galactosidase</keyword>
</DOC>